These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15056527)

  • 1. Extrapyramidal syndrome and long-acting injectable risperidone.
    Adamou M; Hale AS
    Am J Psychiatry; 2004 Apr; 161(4):756-7. PubMed ID: 15056527
    [No Abstract]   [Full Text] [Related]  

  • 2. A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone.
    Remington G; Mamo D; Labelle A; Reiss J; Shammi C; Mannaert E; Mann S; Kapur S
    Am J Psychiatry; 2006 Mar; 163(3):396-401. PubMed ID: 16513859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Time to evaluate long-acting neuroleptics?
    Watt DC
    Psychol Med; 1975 Aug; 5(3):222-6. PubMed ID: 1161960
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic.
    Fleischhacker WW; Eerdekens M; Karcher K; Remington G; Llorca PM; Chrzanowski W; Martin S; Gefvert O
    J Clin Psychiatry; 2003 Oct; 64(10):1250-7. PubMed ID: 14658976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New for old? Risperidone long-acting injection in older patients.
    Hudson-Jessop P; Hughes B; Brinkley N
    Australas Psychiatry; 2007 Dec; 15(6):461-4. PubMed ID: 17999255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone-induced extrapyramidal reactions.
    Mahmood T; Clothier EB; Bridgman R
    Lancet; 1995 Nov; 346(8984):1226. PubMed ID: 7475677
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-acting phenothiazine preparations in the treatment of schizophrenia.
    Kernohan GA
    Br J Psychiatry; 1972 Jan; 120(554):126-7. PubMed ID: 5041515
    [No Abstract]   [Full Text] [Related]  

  • 8. Once-monthly paliperidone palmitate compared with conventional and atypical daily oral antipsychotic treatment in patients with schizophrenia.
    Kim E; Correll CU; Mao L; Starr HL; Alphs L
    CNS Spectr; 2016 Dec; 21(6):466-477. PubMed ID: 27629292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity.
    Rubio G; Martínez I; Ponce G; Jiménez-Arriero MA; López-Muñoz F; Alamo C
    Can J Psychiatry; 2006 Jul; 51(8):531-9. PubMed ID: 16933590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical application of pharmacotherapy with long-acting risperidone for patients with schizophrenia.
    Keith SJ; Pani L; Nick B; Emsley R; San L; Turner M; Conley R; Scully P; Chue PS; Lachaux B
    Psychiatr Serv; 2004 Sep; 55(9):997-1005. PubMed ID: 15345759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
    Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
    J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia.
    Dursun S
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy with injectable fluphenazines.
    Ayd FJ
    Curr Psychiatr Ther; 1976; 16():177-89. PubMed ID: 991628
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic.
    Kane JM; Eerdekens M; Lindenmayer JP; Keith SJ; Lesem M; Karcher K
    Am J Psychiatry; 2003 Jun; 160(6):1125-32. PubMed ID: 12777271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interaction between risperidone and phenytoin resulting in extrapyramidal symptoms.
    Sanderson DR
    J Clin Psychiatry; 1996 Apr; 57(4):177. PubMed ID: 8601557
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical review of a long-acting, injectable formulation of risperidone.
    Knox ED; Stimmel GL
    Clin Ther; 2004 Dec; 26(12):1994-2002. PubMed ID: 15823763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions.
    McClelland HA
    Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):401-3. PubMed ID: 9966
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed severe extrapyramidal disturbance following frequent depot phenothiazine administration.
    Warner AM; Wyman SM
    Am J Psychiatry; 1975 Jul; 132(7):743-5. PubMed ID: 1137022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidone.
    Martin SD; Libretto SE; Pratt DJ; Brewin JS; Huq ZU; Saleh BT
    Curr Med Res Opin; 2003; 19(4):298-305. PubMed ID: 12841922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.